136 related articles for article (PubMed ID: 32357340)
1. Analyzing the role of adjuvant or salvage radiotherapy for spinal myxopapillary ependymomas.
Kotecha R; Tom MC; Naik M; Angelov L; Benzel EC; Reddy CA; Prayson RA; Kalfas I; Schlenk R; Krishnaney A; Steinmetz MP; Bingaman W; Suh JH; Chao ST
J Neurosurg Spine; 2020 May; 33(3):392-397. PubMed ID: 32357340
[TBL] [Abstract][Full Text] [Related]
2. Outcomes following myxopapillary ependymoma resection: the importance of capsule integrity.
Abdulaziz M; Mallory GW; Bydon M; De la Garza Ramos R; Ellis JA; Laack NN; Marsh WR; Krauss WE; Jallo G; Gokaslan ZL; Clarke MJ
Neurosurg Focus; 2015 Aug; 39(2):E8. PubMed ID: 26235025
[TBL] [Abstract][Full Text] [Related]
3. Metastases of spinal myxopapillary ependymoma: unique characteristics and clinical management.
Kraetzig T; McLaughlin L; Bilsky MH; Laufer I
J Neurosurg Spine; 2018 Feb; 28(2):201-208. PubMed ID: 29219779
[TBL] [Abstract][Full Text] [Related]
4. Tumor control after surgery for spinal myxopapillary ependymomas: distinct outcomes in adults versus children: a systematic review.
Feldman WB; Clark AJ; Safaee M; Ames CP; Parsa AT
J Neurosurg Spine; 2013 Oct; 19(4):471-6. PubMed ID: 23971762
[TBL] [Abstract][Full Text] [Related]
5. Adjuvant radiotherapy delays recurrence following subtotal resection of spinal cord ependymomas.
Oh MC; Ivan ME; Sun MZ; Kaur G; Safaee M; Kim JM; Sayegh ET; Aranda D; Parsa AT
Neuro Oncol; 2013 Feb; 15(2):208-15. PubMed ID: 23229996
[TBL] [Abstract][Full Text] [Related]
6. Management of pediatric myxopapillary ependymoma: the role of adjuvant radiation.
Agbahiwe HC; Wharam M; Batra S; Cohen K; Terezakis SA
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):421-7. PubMed ID: 22713833
[TBL] [Abstract][Full Text] [Related]
7. Cumulative survival analysis of patients with spinal myxopapillary ependymomas in the first 2 decades of life.
Kukreja S; Ambekar S; Sin AH; Nanda A
J Neurosurg Pediatr; 2014 Apr; 13(4):400-7. PubMed ID: 24527863
[TBL] [Abstract][Full Text] [Related]
8. Histopathological features predictive of local control of atypical meningioma after surgery and adjuvant radiotherapy.
Chen WC; Magill ST; Wu A; Vasudevan HN; Morin O; Aghi MK; Theodosopoulos PV; Perry A; McDermott MW; Sneed PK; Braunstein SE; Raleigh DR
J Neurosurg; 2018 Apr; 130(2):443-450. PubMed ID: 29624151
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcomes of spinal ependymomas: an institutional experience of more than 60 cases.
Savoor R; Sita TL; Dahdaleh NS; Helenowski I; Kalapurakal JA; Marymont MH; Lukas R; Kruser TJ; Smith ZA; Koski T; Ganju A; Sachdev S
J Neurooncol; 2021 Jan; 151(2):241-247. PubMed ID: 33179213
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant radiotherapy in the treatment of pediatric myxopapillary ependymomas.
Al-Halabi H; Montes JL; Atkinson J; Farmer JP; Freeman CR
Pediatr Blood Cancer; 2010 Oct; 55(4):639-43. PubMed ID: 20806362
[TBL] [Abstract][Full Text] [Related]
11. Outcomes after surgery and radiotherapy for spinal myxopapillary ependymoma: update of the MD Anderson Cancer Center experience.
Tsai CJ; Wang Y; Allen PK; Mahajan A; McCutcheon IE; Rao G; Rhines LD; Tatsui CE; Armstrong TS; Maor MH; Chang EL; Brown PD; Li J
Neurosurgery; 2014 Sep; 75(3):205-14; discussion 213-4. PubMed ID: 24818785
[TBL] [Abstract][Full Text] [Related]
12. Predictors of survival in patients with spinal ependymoma.
Lin Y; Smith ZA; Wong AP; Melkonian S; Harris DA; Lam S
Neurol Res; 2015 Jul; 37(7):650-5. PubMed ID: 25917046
[TBL] [Abstract][Full Text] [Related]
13. Is gross-total resection sufficient treatment for posterior fossa ependymomas?
Rogers L; Pueschel J; Spetzler R; Shapiro W; Coons S; Thomas T; Speiser B
J Neurosurg; 2005 Apr; 102(4):629-36. PubMed ID: 15871504
[TBL] [Abstract][Full Text] [Related]
14. Surgical outcomes and risk factors for recurrence of myxopapillary ependymoma: a single-center experience.
Dougherty MC; Sandhu MRS; Teferi N; Noeller JL; Rosinski CL; Park BJ; Menezes AH; Nourski KV; Hitchon PW
J Neurosurg Spine; 2023 Oct; 39(4):548-556. PubMed ID: 37410596
[TBL] [Abstract][Full Text] [Related]
15. Primary spinal myxopapillary ependymoma in the pediatric population: a study from the Surveillance, Epidemiology, and End Results (SEER) database.
Lucchesi KM; Grant R; Kahle KT; Marks AM; DiLuna ML
J Neurooncol; 2016 Oct; 130(1):133-140. PubMed ID: 27423644
[TBL] [Abstract][Full Text] [Related]
16. Adjuvant radiotherapy versus observation after gross total resection of WHO grade II ependymoma: a systematic review and individual-participant data meta-analysis.
Zheng Y; Ong SH; Nga VDW; Vellayappan B
Chin Clin Oncol; 2024 Apr; 13(2):22. PubMed ID: 38644544
[TBL] [Abstract][Full Text] [Related]
17. Surgical outcomes in spinal cord ependymomas and the importance of extent of resection in children and young adults.
Safaee M; Oh MC; Mummaneni PV; Weinstein PR; Ames CP; Chou D; Berger MS; Parsa AT; Gupta N
J Neurosurg Pediatr; 2014 Apr; 13(4):393-9. PubMed ID: 24506340
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcome of patients with spinal myxopapillary ependymoma: treatment results from the MD Anderson Cancer Center and institutions from the Rare Cancer Network.
Weber DC; Wang Y; Miller R; Villà S; Zaucha R; Pica A; Poortmans P; Anacak Y; Ozygit G; Baumert B; Haller G; Preusser M; Li J
Neuro Oncol; 2015 Apr; 17(4):588-95. PubMed ID: 25301811
[TBL] [Abstract][Full Text] [Related]
19. Ependymoma of the Spinal Cord in Children: A Retrospective French Study.
Szathmari A; Zerah M; Vinchon M; Dufour C; Gimbert E; Di Rocco F; Chabaud S; Conter C; Mottolese C; Frappaz D
World Neurosurg; 2019 Jun; 126():e1035-e1041. PubMed ID: 30877001
[TBL] [Abstract][Full Text] [Related]
20. The role of adjuvant radiation therapy in the treatment of spinal myxopapillary ependymomas.
Chao ST; Kobayashi T; Benzel E; Reddy CA; Stevens GH; Prayson RA; Kalfas I; Schlenk R; Krishnaney A; Steinmetz MP; Bingaman W; Hahn J; Suh JH
J Neurosurg Spine; 2011 Jan; 14(1):59-64. PubMed ID: 21142463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
